<DOC>
	<DOCNO>NCT01704742</DOCNO>
	<brief_summary>This study help researcher learn non-Hodgkin 's lymphoma Hodgkin 's lymphoma treat Kenya . Researchers want see certain virus like Epstein Barr Virus ( EBV ) , Human Immunodeficiency Virus ( HIV ) , Kaposi 's Sarcoma Herpes Virus ( KSHV ) affect lymphoma . Patients Kenya agree study let resesarchers look medical record , follow normal cancer care , blood drawn look different protein virus . Researchers would also like look part original tumor take patient . Some sample store Kenyatta National Hospital research do later . This study involve change treatment , allow study team follow patient Kenya lymphoma treat .</brief_summary>
	<brief_title>Prospective Study Lymphoproliferative Diseases</brief_title>
	<detailed_description>Comprehensive prospective cohort study lymphoproliferative disease Nairobi , Kenya .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Lymphoproliferative Disorders</mesh_term>
	<criteria>All subject regardless age , sex HIV serostatus must biopsyproven nonHodgkin 's ( NHL ) , include primary effusion lymphoma , Hodgkin 's lymphoma ( HD ) lymphoproliferative disorder ( e.g. , Castleman 's disease ) measurable evaluable stage I IV disease . [ Note : Lymphomas categorize basis current WHO classification scheme , recognize initial pathological categorization time study enrollment likely classify grade low , intermediate , highgrade lymphoma Working Formulation criterion . This current standard practice Kenya . ] All subject must receive form systemic chemotherapy . Subjects receive chemotherapy kind eligible . Subjects must prior chemotherapy lymphoma . Subjects may receive prior radiotherapy localize stage I stage II disease clearly document progressed beyond initial radiotherapy port . All subject must give write informed consent participate study . In Kenya , child consider &lt; 18 year age adult â‰¥ 18 year age . All child parental legal guardian provide consent.. Children age 7 &lt; 18 year old give opportunity provide assent . For child age 7 11 year old do use parental consent form assent statement . For child &gt; 11 year old assent document use IRB approve assent form . Subjects fulfill criterion list Sections 3.1.1 3.1.4 ineligible . Subjects receive prior chemotherapy ( i.e. , firstline treatment ) receive chemotherapy nonHodgkin 's ( NHL ) Hodgkin 's lymphoma ( HD ) ineligible .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Non-Hodgkin 's Lymphoma</keyword>
	<keyword>Hodgkin 's Lymphoma</keyword>
	<keyword>Kenya</keyword>
	<keyword>Epstein Barr Virus ( EBV )</keyword>
	<keyword>Human Immunodeficiency Virus ( HIV )</keyword>
	<keyword>Kaposi 's Sarcoma Herpes Virus ( KSHV )</keyword>
</DOC>